Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Literature DB >> 17261621

First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Maria Virginia Villegas¹, Karen Lolans, Adriana Correa, Juan Nicolas Kattan, Jaime A Lopez, John P Quinn.

Abstract

In Medellin, Colombia, three Pseudomonas aeruginosa isolates with high-level carbapenem resistance (MIC>or=256 microg/ml) and an isolate of Citrobacter freundii with reduced susceptibility to imipenem produced the plasmid-mediated class A carbapenemase KPC-2. This is the first report of a KPC-type beta-lactamase identified outside of the family Enterobacteriaceae.

Entities: Chemical Species

Mesh：

Substances：

Year: 2007 PMID： 17261621 PMCID： PMC1855450 DOI： 10.1128/AAC.01405-06

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

25 in total

1. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China.

Authors: Ze-Qing Wei; Xiao-Xing Du; Yun-Song Yu; Ping Shen; Ya-Gang Chen; Lan-Juan Li
Journal: Antimicrob Agents Chemother Date: 2006-12-04 Impact factor: 5.191

2. Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme.

Authors: Mark A Toleman; Alan M Simm; Tanya A Murphy; Ana C Gales; Doug J Biedenbach; Ronald N Jones; Timothy R Walsh
Journal: J Antimicrob Chemother Date: 2002-11 Impact factor: 5.790

3. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Authors: H Yigit; A M Queenan; G J Anderson; A Domenech-Sanchez; J W Biddle; C D Steward; S Alberti; K Bush; F C Tenover
Journal: Antimicrob Agents Chemother Date: 2001-04 Impact factor: 5.191

4. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18.

Authors: J K Rasheed; G J Anderson; H Yigit; A M Queenan; A Doménech-Sánchez; J M Swenson; J W Biddle; M J Ferraro; G A Jacoby; F C Tenover
Journal: Antimicrob Agents Chemother Date: 2000-09 Impact factor: 5.191

5. Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae and Escherichia coli isolates from Colombian hospitals.

Authors: Maria Virginia Villegas; Adriana Correa; Federico Perez; Maria Consuelo Miranda; Tania Zuluaga; John P Quinn
Journal: Diagn Microbiol Infect Dis Date: 2004-07 Impact factor: 2.803

6. Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City.

Authors: Patricia A Bradford; Simona Bratu; Carl Urban; Melissa Visalli; Noriel Mariano; David Landman; James J Rahal; Steven Brooks; Sanda Cebular; John Quale
Journal: Clin Infect Dis Date: 2004-06-14 Impact factor: 9.079

7. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.

Authors: Hesna Yigit; Anne Marie Queenan; J Kamile Rasheed; James W Biddle; Antonio Domenech-Sanchez; Sebastian Alberti; Karen Bush; Fred C Tenover
Journal: Antimicrob Agents Chemother Date: 2003-12 Impact factor: 5.191

8. SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.

Authors: Helio S Sader; Ronald N Jones; Ana C Gales; Juliana B Silva; Antonio C Pignatari
Journal: Braz J Infect Dis Date: 2004-07-20 Impact factor: 1.949

9. Broad resistance due to plasmid-mediated AmpC beta-lactamases in clinical isolates of Escherichia coli.

Authors: R Odeh; S Kelkar; A M Hujer; R A Bonomo; P C Schreckenberger; J P Quinn
Journal: Clin Infect Dis Date: 2002-06-24 Impact factor: 9.079

10. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

Authors: Vivi Miriagou; Leonidas S Tzouvelekis; Shannon Rossiter; Eva Tzelepi; Frederick J Angulo; Jean M Whichard
Journal: Antimicrob Agents Chemother Date: 2003-04 Impact factor: 5.191

105 in total

1. Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.

Authors: Thérèse Stachyra; Marie-Claude Péchereau; Jean-Michel Bruneau; Monique Claudon; Jean-Marie Frère; Christine Miossec; Kenneth Coleman; Michael T Black
Journal: Antimicrob Agents Chemother Date: 2010-10-04 Impact factor: 5.191

2. First description of KPC-2-producing Pseudomonas putida in Brazil.

Authors: Anna C S Almeida; Marinalda A Vilela; Felipe L S Cavalcanti; Willames M B S Martins; Marcos A Morais; Marcia M C Morais
Journal: Antimicrob Agents Chemother Date: 2012-01-30 Impact factor: 5.191

Review 3. Current concepts in laboratory testing to guide antimicrobial therapy.

Authors: Stephen G Jenkins; Audrey N Schuetz
Journal: Mayo Clin Proc Date: 2012-03 Impact factor: 7.616

4. First report of KPC-producing Pseudomonas aeruginosa in Brazil.

Authors: Paula Regina Luna de Araújo Jácome; Lílian Rodrigues Alves; Adriane Borges Cabral; Ana Catarina S Lopes; Maria Amélia Vieira Maciel
Journal: Antimicrob Agents Chemother Date: 2012-07-02 Impact factor: 5.191

5. Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors: Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal: Antimicrob Agents Chemother Date: 2010-04-26 Impact factor: 5.191

6. Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity.

Authors: David Landman; Carl Urban; Martin Bäcker; Paul Kelly; Neha Shah; Elizabeth Babu; Simona Bratu; John Quale
Journal: J Clin Microbiol Date: 2010-10-06 Impact factor: 5.948